Laboratorios Farmaceuticos Rovi SA 2018 SR
The report highlights ROVI's 2018 performance as a fully-integrated pharmaceutical company, emphasizing its growth in the low-molecular-weight heparin (LMWH) market and toll manufacturing. A major milestone was the international launch of an enoxaparin biosimilar across several European countries. The company significantly increased its R&D investment to 32.4 million euros, focusing on its proprietary ISM® technology for schizophrenia and breast cancer treatments. ROVI also successfully executed an 88 million euro capital increase to support clinical trials and acquisitions. Environmental stewardship was reinforced through the transition to ISO 14001:2015 standards at its main production plants, while social initiatives focused on workplace inclusion for people with disabilities and support for medical research.
Company: Laboratorios Farmaceuticos Rovi SA
Sector: Manufacturing
Country: Spain
Year: 2018
Type: SR
Pages: 80
Laboratorios Farmaceuticos Rovi SA
The report highlights ROVI's 2018 performance as a fully-integrated pharmaceutical company, emphasizing its growth in the low-molecular-weight heparin (LMWH) market and toll manufacturing. A major milestone was the international launch of an enoxaparin biosimilar across several European countries. The company significantly increased its R&D investment to 32.4 million euros, focusing on its proprietary ISM® technology for schizophrenia and breast cancer treatments. ROVI also successfully executed an 88 million euro capital increase to support clinical trials and acquisitions. Environmental stewardship was reinforced through the transition to ISO 14001:2015 standards at its main production plants, while social initiatives focused on workplace inclusion for people with disabilities and support for medical research.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees